GUCA2B and inflammatory bowel disease: Uroguanylin (encoded by GUCA2B) could bind to the guanylate cyclase-C receptor and activate the CFTR to regulate the fluid secretion and exhibit the downregulated expression in inflammatory bowel disease (Brenna et al., 2015; Field, 2003).